E. Suárez

Efficacy, immunogenicity, and safety of a 9-valent human papillomavirus vaccine in Latin American girls, boys, and young women

J. C. Reina, E. Moreira, E. Lazcano-Ponce, 2017, Papillomavirus research.

HPV genotyping from invasive cervical cancer in Chile

J. Roa, F. Gaete, P. García, 2009, International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics.

Cost-effectiveness of vaccination against cervical cancer: a multi-regional analysis assessing the impact of vaccine characteristics and alternative vaccination scenarios.

Chien-Jen Chen, Jennifer S. Smith, B. Standaert, 2008, Vaccine.

Genotyping of human papillomavirus in cervical intraepithelial neoplasia in a high‐risk population

J. Roa, Pamela Leal, P. García, 2011, Journal of medical virology.

P926 Modelling the impact of different vaccine profiles on the cost‐effectiveness of HPV vaccination in the Chilean setting

B. Standaert, N. Demarteau, E. Suárez, 2009 .

Maternal transfer of anti HPV 6 and 11 antibodies upon immunization with the 9-valent HPV vaccine

A. Hirschberg, O. Bautista, A. Luxembourg, 2018, Human vaccines & immunotherapeutics.

Ovarian squamous cell carcinoma

E. Suárez, R. Assad, Paulina Reyes Tobar, 2020, Journal of cancer research and therapeutics.